■ COVID-19: impact of and on diabetes
Jonathan Schofield, Lalantha Leelarathna, Hood Thabit
Diabetes Ther. 2020 Jul; 11(7): 1429–143
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275119/
■ Notas de esclarecimentos da Sociedade Brasileira de Diabetes sobre o coronavirus (COVID-19)
https://www.diabetes.org.br/publico/notas-de-esclarecimentos-da-sociedade-brasileira-de-diabetes-sobre-o-coronavirus-covid-19
■ Síndrome metabólica e COVID-19: onde as vias se cruzam
L R Giacaglia
https://www.diabetes.org.br/covid-19/sindrome-metabolica-e-covid-19-onde-as-vias-se-cruzam/
■ COVID-19 and diabetes: knowledge in progress
Akhtar Hussain, Bishwajit Bhowmik, Nayla Cristina do Vale Moreira
Diabetes Res Clin Pract. 2020 Apr; 162: 10814
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144611/
■ Type 2 diabetes as a major risk factor for COVID-19 severity: a meta-analysis
Pinto, Lana C. and Bertoluci, Marcello C
Arch. Endocrinol. Metab., June 2020, vol.64, no.3, p.199-200
https://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972020000300199&lng=en&nrm=iso
■ COVID-19 and diabetes mellitus: an unholy interaction of two pandemicas
Rimesh Pal, Sanjay K. Bhadada
Diabetes Metab Syndr. 2020 July-August; 14(4): 513–51
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202837/
■ SARS-CoV-2 disease severity and diabetes: why the connection and what is to be done?
Caio Henrique Mazucanti, Josephine Mary Egan
Immun Ageing. 2020; 17: 21
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325192/
■ Glycaemic control among people with type 1 diabetes during lockdown for the SARS-CoV-2 outbreak in Italy
Benedetta Maria Bonora, Federico Boscari, Angelo Avogaro et al
Diabetes Ther. 2020 Jun; 11(6): 1369–1379
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213551/
■ Risk and predictors of in-hospital mortality from COVID-19 in patients with diabetes and cardiovascular disease
Hadith Rastad, Hossein Karim, Hanieh-Sadat Ejtahed, et al
Diabetol Metab Syndr. 2020; 12: 57
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338100/
■ Low dose chloroquine decreases insulin resistance in human metabolic syndrome but does not reduce carotid intima-media thickness
Janet B. McGill, Mariko Johnson, Stacy Hurst, et al
Diabetol Metab Syndr. 2019; 11: 61
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664523/
■ Diabetes, infection risk and COVID-19
Suheda Erener
Mol Metab. 2020 Jun 23 : 101044
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308743/
■ Dr Paulo Fernando Leite
Cardiologia/Prevenção Cardiovascular
Estratificação de Risco Cardiovascular
Consultório: Rua Padre Rolim 815/sala 601 – Belo Horizonte/MG/Brasil
Tel: 33245518
CRMMG: 7026
Email: pfleite1873@gmail.com
Blog Internet Médica – www.internetmedica.com.br
Data: julho 2020